MeSH D018288 - small cell carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Topotecan | Topotecan Teva |  | 2009-09-21 |  |  |
| Cisplatin | Cisplatin |  | 2000-05-16 |  |  | |
| Novast Laboratories | Topotecan | Topotecan |  | 2016-11-30 |  |  |
| Rising Pharmaceuticals | Topotecan | Topotecan |  | 2012-08-28 |  |  |
| Sandoz | Topotecan | Hycamtin |  | 1996-05-28 |  |  |
| Topotecan | Topotecan |  | 2011-02-25 |  |  | |
| Pfizer | Topotecan | Topotecan Hospira |  | 2010-06-09 |  |  |
| Dr Reddys Laboratories | Topotecan | Topotecan |  | 2011-03-09 |  |  |
| Sun Pharmaceutical Industries | Topotecan | Topotecan |  | 2013-08-29 |  |  |
| Hospira | Topotecan | Topotecan |  | 2011-02-02 |  |  |
| Accord Healthcare | Topotecan | Topotecan |  | 2013-06-26 |  |  |
| Cisplatin | Cisplatin |  | 2015-08-18 |  |  | |
| Smithkline Beecham | Topotecan | Evotopin |  | 1997-04-15 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
75%18/24
Phase 2
11%5/44
Phase 3
33%3/9
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use